World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 19 February 2018
Main ID:  ISRCTN52284448
Date of registration: 14/04/2016
Prospective Registration: Yes
Primary sponsor: University of A Coruña
Public title: Parkinson's disease, exercise and cognitive training
Scientific title: Effects of the combination of physical exercise and cognitive training on cognitive functions in patients with Parkinson's disease
Date of first enrolment: 01/06/2016
Target sample size: 60
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN52284448
Study type:  Interventional
Study design:  Single-centre randomised parallel trial (Quality of life)  
Phase: 
Countries of recruitment
Spain
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Miguel    Fernández del Olmo
Address:  Departamento de Educación Física e Deportiva Facultade de Ciencias do Deporte e a Educación Física (INEF Galicia) Avd. Ernesto Che Guevara 121, Pazos-Liáns 15179 A Coruña Spain
Telephone: +34 981167000
Email: mafo@udc.es
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Aged 40–80 years
2. Diagnosed with PD according to UK PD Society Brain Bank Criteria.26
3. Disease severity of Hoehn and Yahr (H&Y) stages I–III

Exclusion criteria: 1. Significant cognitive impairment (Mini-Mental State Examination < 23)
2. Below average premorbid intelligence (vocabulary subtest, Wechsler Adult Intelligence Scale-III [WAIS-III] typical score < 40)
3. Major depression (GDS-15 > 10)
4. Severe auditory or visual deficits
5. Another psychiatric/neurological condition


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Parkinson's disease
Nervous System Diseases
Parkinson's disease
Intervention(s)
Patients will be allocated randomly in two groups, a group of multimodal intervention (physical exercise + cognitive training) and a group of unimodal intervention (cognitive training).

Group 1: Participants complete cognitive training alone. This involves completing computer tasks, individualized for the cognitive capacity, using the software SmartBrain (http://www.smartbrain.net/). Participants complete three sessions a weeks for eight weeks, lasting for around 64 minutes per session.

Group 2: Participants complete the cognitive training whiles walking on a treadmill, by using touch screen technology. Participants complete three sessions a weeks for eight weeks, lasting for around 64 minutes per session.

Two weeks before and after the training programs, clinical, motor, neuropsychogical and neurophysiological evaluations will be conducted. A two month follow up will also be performed.
Primary Outcome(s)
1. Cognitive performance is measured using CDS (Cognitive Difficulties Scale), WAIS-III (Wechsler Adult Intelligence Scale-III), Digital Span Forward and backwards, Trail Making Test A and B, Stroop Test, Corsi Block, Verbal Fluency (FAS), Tower of London and Wilcoxin Card Sorting Test at 2 month before intervention, 2 weeks before intervention (baseline), 2 weeks post-intervention and two months post-intervention (follow-up)
2. Motor performance is measured using walk at comfortable speed, Time Up & Go and walk with dual-task at 2 month before intervention, 2 weeks before intervention (baseline), 2 weeks post-intervention and two months post-intervention (follow-up)
3. Quality of life is measured using ADLS (Activities of Dayly Living Scale), QOLS (Quality Of Life Scale) and IPAQ (International Physical Activity Questionnaire) at 2 month before intervention, 2 weeks before intervention (baseline), 2 weeks post-intervention and two months post-intervention (follow-up)
Secondary Outcome(s)
1. Functional connectivity is measured using evoked related potentials at 2 weeks before intervention (baseline) and 2 weeks post-intervention
2. White matter is measured using diffusion tensor imaging at 2 weeks before intervention (baseline) and 2 weeks post-intervention

Secondary ID(s)
DEP2014-53896-R
Source(s) of Monetary Support
Ministerio de Economía y Competitividad
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Ethics committee of University of A Coruña, 30/12/2015, ref: 20/2014
Results
Results available: Yes
Date Posted:
Date Completed: 15/01/2018
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history